TauTona Group
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment (NCT04058197) | TauTona Group | 2020-07-21 |
Track TauTona Group automatically
Every clearance here is in the API, with alerts when new ones post.